Profile of adherence to highly active antiretroviral therapy of patients older than 50 years old

Journal of Acquired Immune Deficiency Syndromes

Volumn 52, Issue 2, 2009, Pages 301-303

  Pardi, Guilherme R ^a   Nunes, Altacílio A ^b   Preto, Ribeirão ^c   Canassa, Paulo Guilherme F ^a   Correia, Dalmo ^a  

^a Federal University of the Tri ngulo Mineiro   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Federal University of the Triĝngulo Mineiro ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; COGNITIVE DEFECT; CONSULTATION; CONTROLLED STUDY; DEPRESSION; FEMALE; GERIATRIC DEPRESSION SCALE; GROUPS BY AGE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PATIENT COMPLIANCE; PRIORITY JOURNAL;

AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED;

EID: 70349660057     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181b065ee     Document Type: Letter

References (13)

1. UNAIDS. A Global View of HIV Infection: 2006 Global Report Prevalence. Report on the Global AIDS Epidemic. UNAIDS; May 2006.
2. UNAIDS. A Global View of HIV Infection: 2007 Global Report Prevalence. Report on the Global AIDS Epidemic. UNAIDS; May 2007.
3. Centers for Disease Control and Prevention. AIDS among persons aged 50 yearsdUnited States 1991-1996. MMWR Morb Mortal Wkly Rep. 1998;47:21-27.
4. Grabar S, Weiss L, Costagliola D. HIV infection in older patients in the HAART era. J Antimicrob Chemother. 2006;57:4-7.
5. Delfraissy J. Prise en charge thèrapeutique des personnes infectées par le VIH. Recommandations dy groupe d'experts. Rapport. Paris: Flammarion Médecine-Sciences; 2004: 224, 284.
6. Araú jo VLB, Brito DMSM, Gimeniz T, et al. Caracterýsticas da Aids na terceira idade em um hospital de referencia do Estado do Ceará, Brasil. Revista Brasileira de Epidemiologia. 2007;10:544-554.
7. Andrew C, David AC. Adverse effects of retroviral therapy. Adverse drugs reactions. Lancet. 2000;356:1423-1430.
8. Nemes MIB Org. Aderencia ao tratamento por anti-retrovirais em servicxos públicos do estado de. Sao Paulo. Brasýlia: Ministério da Saúde; 2000.
9. Hofer CB, Schechter M, Harrison LH. Effectiveness of antiretroviral therapy among patients who attend public HIV clinics in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr. 2004;36:967-971.
10. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12: 189-198.
11. Wenger NA, Gifford A, Liu H, et al. Patient characteristics and attitudes associated with antiretroviral (AR) adherence. In: Conference on Retroviruses and Opportunistic Infections; Chicago, IL; 1999. Abstract 98.
12. Starace F, Ammassari A, Trotta MP, et al. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002; 31(Suppl 3):S136-S139. (Pubitemid 35453574)
13. Heaton RK, Marcotte TD, Mindt MR, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004;10:317-331.